Stem Cell Orthopedic Applauds New Study Showing Platelet Rich
Plasma Therapy Significantly Improving Clinical Results in Patients with
Tennis Elbow.
StemCellOrthopedic.com, popular website of the Institute of Regenerative
and Molecular Orthopaedics (IRMO), world renowned stem cell therapy
experts, applauds a recent study displaying the efficacy of platelet
rich plasma (PRP) therapy in treating patients with tennis elbow. This
study comes on the heels of a wave of recent research exploring the
effectiveness of PRP therapy
on torn tendons, muscles, and more. This comes as good news to people
around the world suffering from tennis elbow and many other painful
ailments.
The analysis, from the Rothman Institute at Jefferson, included a
multi-center randomized prospective study to research the clinical value
of PRP. The study utilized 230 patients with chronic tennis elbow,
where virtually one half was treated with PRP and the other half was the
control group. The PRP group received single PRP injections into their extensor tendon.
Both groups were studied for up to 24 weeks. By week 12, the PRP group
reported a 55% improvement in pain, versus 47% for the control group.
Concurrently, at week 12, the PRP group reported 37.4% significant elbow
tenderness, compared to 48% from the control group. By the end of 24
weeks, the PRP group reported an outstanding 29% significant tenderness
rating, versus 54% from the control.
Read more:
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου